Skip to main content

REVIEW article

Front. Med.
Sec. Ophthalmology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1533161
This article is part of the Research Topic Reviews in: Ophthalmology 2024 View all 4 articles

Clinical Outcomes of a Hydrophobic Trifocal Diffractive Intraocular Lens: A Literature Review

Provisionally accepted
Deborah Ristvedt Deborah Ristvedt 1Camile Bosc Camile Bosc 2*Vance Thompson Vance Thompson 3,4
  • 1 Vance Thompson Vision, Alexandria, United States
  • 2 Institut Ophtalmologique de l'Ouest (IOO) Jules Verne, Nantes, France
  • 3 Vance Thompson Vision, Sioux Falss, United States
  • 4 University of South Dakota, Sioux Falls, United States

The final, formatted version of the article will be published soon.

    The aim of this review is to summarize the clinical outcomes reported in patients following the implantation of the hydrophobic diffractive trifocal FineVision HP intraocular lens (IOL). A literature search in PubMed (U.S. National Library of Medicine) was performed to identify publications, both prospective and retrospective, which have reported the clinical outcomes of patients who were implanted with this IOL model after cataract or refractive lens exchange surgeries. A total of 18 clinical studies published between 2019 and 2024 were included in this review. The available data reported in the different clinical publications was analyzed in detail, focusing mainly on refraction, visual acuity, the defocus curve, optical quality, contrast sensitivity, and patient-reported outcome questionnaires. In addition, the adverse events and other measurements reported in some studies were also analyzed. Our review encompassed a total of 1028 eyes analyzed at different follow-up periods up to a maximum of 24 months. The analysis carried out in this review leads us to conclude that the FineVision HP IOL provides good refractive outcomes and excellent visual performance when implanted.

    Keywords: Trifocal, Intraocular lens, hydrophobic, Diffractive, Defocus curve

    Received: 23 Nov 2024; Accepted: 03 Jan 2025.

    Copyright: © 2025 Ristvedt, Bosc and Thompson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Camile Bosc, Institut Ophtalmologique de l'Ouest (IOO) Jules Verne, Nantes, France

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.